Received:
Wednesday, December 16, 2020
Commodity:
Plant-Derived Recombinant Human Serum Albumins ("rHSA") and Products Containing Same
Investigation Number:
337-TA-1238
Filed By:
Beau Jackson
Firm/Organization:
Husch Blackwell, LLP
Behalf Of:
Ventria Bioscience Inc.
Confidential:
Yes
Country:
None
Description:
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding certain plant-derived recombinant human serum albumins (“rHSA”) and products containing same. The proposed respondents are Wuhan Healthgen Biotechnology Corp., China; ScienCell Research Laboratories, Inc., Carlsbad, CA; Aspira Scientific, Inc., Milpitas, CA; United States Biological Corporation, Salem, MA; eEnzyme LLC, Gaithersburg, MD; and antibodies-online, Inc., Germany.
Petition/Complaint Status:
Instituted
An official website of the United States government.